GUIDED THERAPEUTICS INC

GTHP

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001477932-26-001162
Filing date: Mar 4, 2026
Earliest execution date: Feb 25, 2026
Reporting Owners: JAMES MICHAEL C (Director)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-02-25-05:00

Code

X

Net shares

+100,000.0

Acquired/Disposed

Acquired

Shares Owned Before

553,495.0

Shares Owned After

653,495.0

Derivative Transactions

Transaction 1

Security

Warrants

Action

Sell

Date

2026-02-25-05:00

Code

J

Net shares

-100,000.0

Acquired/Disposed

Disposed

Shares Owned Before

100,000.0

Shares Owned After

0.0

Transaction 2

Security

Warrants

Action

Buy

Date

2026-02-25-05:00

Code

J

Net shares

+100,000.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

100,000.0

Transaction 3

Security

Warrants

Action

Sell

Date

2026-02-25-05:00

Code

J

Net shares

-100,000.0

Acquired/Disposed

Disposed

Shares Owned Before

100,000.0

Shares Owned After

0.0

Transaction 4

Security

Warrants

Action

Buy

Date

2026-02-25-05:00

Code

J

Net shares

+100,000.0

Acquired/Disposed

Acquired

Shares Owned Before

52,778.0

Shares Owned After

152,778.0

Transaction 5

Security

Warrants

Action

Exercise

Date

2026-02-25-05:00

Code

X

Net shares

-100,000.0

Acquired/Disposed

Disposed

Shares Owned Before

152,778.0

Shares Owned After

52,778.0

Filing's footnotes

1. During February 2026, Mr. James signed an exchange agreement to exchange 100,000 warrants to purchase shares of common stock with an exercise price of $0.65 for 100,000 warrants to purchase shares of common stock for an exercise price of $0.25. The newly exchanged warrants were subsequently exercised upon payment of $25,000. Moreover, as part of the exchange agreement, the expiration date of 4-year 100,000 warrants to purchase shares of common stock with exercise price of $0.50 was extended for an additional year, until September 1, 2027.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.